Kieran Rothnie
Chief Scientist Office(GB)GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research, Respiratory Support and Mechanisms
Most-Cited Works
- → Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice–based Population with Chronic Obstructive Pulmonary Disease(2018)205 cited
- → Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records(2016)169 cited
- → Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis(2015)144 cited
- → Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation(2015)124 cited
- → Benefits of Incentives for Breastfeeding and Smoking cessation in pregnancy (BIBS): a mixed-methods study to inform trial design(2015)107 cited
- → Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records(2016)95 cited
- → Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease(2018)88 cited
- → Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease(2015)78 cited
- → Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care(2017)54 cited
- → Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting(2022)45 cited